指南与共识乳腺癌

早期乳腺癌腋窝管理:安大略健康(癌症护理安大略)与ASCO指南

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline.
指南 / 共识 · J Clin Oncol · 2021-07-19

该指南由安大略健康(癌症护理安大略)与ASCO召集工作组和专家组,基于系统综述制定早期乳腺癌腋窝管理推荐。指南认可ASCO 2017年关于前哨淋巴结活检的两条推荐,并扩展了放疗干预、新辅助化疗后分期时机及示踪方法等推荐。证据基础包括ASCO 2017指南、七项高质量系统综述、54项独特研究和65项验证试验。

要点

  • 指南针对早期乳腺癌腋窝分期、治疗时机和方式给出推荐。
  • 认可ASCO 2017前哨淋巴结活检推荐并扩展放疗等推荐。
  • 证据基于系统综述及多项研究。

核心结论

  • 指南为早期乳腺癌腋窝管理提供循证推荐,涵盖分期、治疗时机和示踪方法。

研究设计与样本

  • 由安大略健康(癌症护理安大略)和ASCO召集工作组与专家组,基于系统文献综述制定推荐。

主要发现

  • 证据基础包括ASCO 2017指南、七项高质量系统综述、54项独特研究和65项验证试验。

关键数值与推荐

  • 指南认可ASCO 2017指南中关于早期乳腺癌前哨淋巴结活检的两条推荐。
  • 推荐涉及五个目标:确定需腋窝分期的患者、未接受新辅助化疗且前哨淋巴结阴性者的进一步腋窝治疗、未接受新辅助化疗且前哨淋巴结阳性者的腋窝策略、新辅助化疗时的腋窝治疗及时机、识别前哨淋巴结的最佳方法。

临床怎么用

  • 临床可根据指南推荐对早期乳腺癌患者进行腋窝分期和治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To provide recommendations on the best strategies for the management and on the best timing and treatment (surgical and radiotherapeutic) of the axilla for patients with early-stage breast cancer. METHODS: Ontario Health (Cancer Care Ontario) and ASCO convened a Working Group and Expert Panel to develop evidence-based recommendations informed by a systematic review of the literature. RESULTS: This guideline endorsed two recommendations of the ASCO 2017 guideline for the use of sentinel lymph node biopsy in patients with early-stage breast cancer and expanded on that guideline with recommendations for radiotherapy interventions, timing of staging after neoadjuvant chemotherapy (NAC), and mapping modalities. Overall, the ASCO 2017 guideline, seven high-quality systematic reviews, 54 unique studies, and 65 corollary trials formed the evidentiary basis of this guideline. RECOMMENDATIONS: Recommendations are issued for each of the objectives of this guideline: (1) To determine which patients with early-stage breast cancer require axillary staging, (2) to determine whether any further axillary treatment is indicated for women with early-stage breast cancer who did not receive NAC and are sentinel lymph node-negative at diagnosis, (3) to determine which axillary strategy is indicated for women with early-stage breast cancer who did not receive NAC and are pathologically sentinel lymph node-positive at diagnosis (after a clinically node-negative presentation), (4) to determine what axillary treatment is indicated and what the best timing of axillary treatment for women with early-stage breast cancer is when NAC is used, and (5) to determine which are the best methods for identifying sentinel nodes.Additional information is available at www.asco.org/breast-cancer-guidelines.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Brackstone M, Baldassarre FG, Perera FE, et al. Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline. J Clin Oncol. 2021. PMID: 34279999. doi:10.1200/JCO.21.00934

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。